13C-Mixed Triglyceride Breath Test to Assess Oral Enzyme Substitution Therapy in Patients With Chronic Pancreatitis J. Enrique Domínguez–Muñoz, Julio Iglesias–García, María Vilariño–Insua, Marta Iglesias–Rey Clinical Gastroenterology and Hepatology Volume 5, Issue 4, Pages 484-488 (April 2007) DOI: 10.1016/j.cgh.2007.01.004 Copyright © 2007 AGA Institute Terms and Conditions
Figure 1 Coefficient of fat absorption (%) and 13CO2 CRR (%) in the context of the 13C-MTG breath test in patients with pancreatic exocrine insufficiency secondary to chronic pancreatitis. Individual values, mean (horizontal line), and 25th–75th percentiles (box) before (basal) and during enzyme substitution therapy (treatment) are shown. The lower limits of normal are shown as a dotted line. Clinical Gastroenterology and Hepatology 2007 5, 484-488DOI: (10.1016/j.cgh.2007.01.004) Copyright © 2007 AGA Institute Terms and Conditions
Figure 2 13CO2 CRR (%) in the 13C-MTG breath test in patients with chronic pancreatitis–related pancreatic exocrine insufficiency during therapy with oral pancreatic extracts. Results (individual data; mean, horizontal line; 25th–75th percentiles, box) before and after therapeutic modification are shown. The lower limit of normal is shown as a dotted line. Clinical Gastroenterology and Hepatology 2007 5, 484-488DOI: (10.1016/j.cgh.2007.01.004) Copyright © 2007 AGA Institute Terms and Conditions
Figure 3 Body weight (kg) in patients with chronic pancreatitis–related pancreatic exocrine insufficiency during therapy with oral pancreatic extracts. Results (individual data; mean, horizontal line; 25th–75th percentiles, box) before and after therapeutic modification are shown. Clinical Gastroenterology and Hepatology 2007 5, 484-488DOI: (10.1016/j.cgh.2007.01.004) Copyright © 2007 AGA Institute Terms and Conditions
Figure 4 Serum levels of (A) RBP and (B) prealbumin in patients with chronic pancreatitis–related pancreatic exocrine insufficiency during therapy with oral pancreatic extracts. Results (individual data; mean, horizontal line; 25th–75th percentiles, box) before and after therapeutic modification are shown. The lower limits of normal are shown as a dotted line. Clinical Gastroenterology and Hepatology 2007 5, 484-488DOI: (10.1016/j.cgh.2007.01.004) Copyright © 2007 AGA Institute Terms and Conditions